New phase I study explores trivalent conjugate vaccine against invasive Salmonella disease Oct. 17, 2019
Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept Oct. 15, 2019
Prokarium receives funding from Wellcome for clinical development of lead vaccine program Oct. 10, 2019
RSS